Searched for
ZYDUS WELLNESS PRODUCTS LTD
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- India’s consumer demand remains resilient despite Iran war, inflation pressures; FMCG firms stay cautiously optimisticDespite geopolitical turmoil and inflation, domestic consumption of essentials and personal care products remains resilient. Company execut...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Bond yields, FIIs and corporate actions among 8 factors to steer D-Street this weekNifty closed marginally higher last week, driven by IT and energy stocks, as markets brace for key events. Technical analysts suggest Nifty...
- Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the J...
- Bayer bets big on 'self-care' market to deepen India playGlobal pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market e...
- Zydus Lifesciences to pursue acquisitions in specialty, rare diseasesZydus Lifesciences is set to acquire US firm Assertio Holdings for $166.40 million. This move aims to build a strong specialty oncology bus...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- India’s consumer sector sees funding dip but deal activity surges in FY26Indian consumer sector investment declined in FY26. Investors are now favoring smaller, diversified deals over large bets. Deal volume, how...
- Discretionary spending slows in India as uncertainty keeps consumer purchases at a bare minimumConsumers are cutting back on non-essential purchases due to global tensions and job worries. Indian households are prioritising savings an...
- Zydus Wellness taps Milind Soman as brand ambassador for Glucon-D rechargeZydus Wellness has appointed actor Milind Soman as the brand ambassador for its new product, Glucon-D Recharge. This marks the company's en...
- 'Weighty' FMCG matters: Prices repacked, value unpacked; Daily goods makers repurpose pack sizes to pass GST cut benefitsPopular price points for daily essentials are set to return by mid-November. FMCG manufacturers can now increase pack weights instead of re...
- HC restrains Cipla from using 'Gluco-C' or 'Gluco-D' trademarksZydus Wellness Products, which manufactures and sells energy drink GLUCON-C and GLUCON-D, had alleged that Cipla Health's Gluco-C and Gluco...
- Zydus Lifesciences Q4 Results: Consolidated net profit dips 25% to Rs 297 croreZydus Lifesciences Ltd reported a 25.36% decline in consolidated net profit at Rs 296.6 crore in the fourth quarter ended March 31, 2023 im...
- Zydus Wellness Q3 net profit at Rs 4 croreThe company had reported a net profit of Rs 39.69 crore for the corresponding period of the previous fiscal
- Nutralite's look-alike by Everlike Food Products gets restrained by Delhi High CourtZydus Wellness received ex-parte restraining orders from Delhi HC against look-alike brands and products that resemble its flagship brand N...
- Zydus Wellness Q4 net profit up 59% at Rs 37 croreThe company had posted net profit of Rs 23.5 crore for the January-March quarter in 2011-12, Zydus Wellness said in a filing to BSE.
Load More
